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Microsatellite instability (MI), the phenotypic manifestation of
mismatch repair failure, is detectable in a wide variety of human
cancers. It is particularly seen in patients with the hereditary 
non-polyposis colon cancer (HNPCC) syndrome, in which the
affected individual is at risk of developing carcinoma both at an
early age and at a range of sites such as the colon, endometrium,
urinary tract and stomach (Aaltonen et al, 1993; Marra and
Boland, 1995; Lynch et al, 1996). Germline mutation in one of the
DNA mismatch repair genes is responsible for a significant
proportion of individuals affected by this syndrome (Fishel et al,
1993; Bronner et al, 1994; Liu et al, 1994; Nicolaides et al, 1994;
Papadopoulos et al, 1994). MI has also been detected in a variable
proportion of the sporadic form of cancer arising in these organs
(Eshleman and Markowitz, 1995).
Although gastric cancer, worldwide, is deemed to be both the
second most common malignancy and second leading cause of
cancer death (Parkin et al, 1993; Pisani et al, 1993), the incidence
varies markedly in different populations. The incidence of molec-
ular genetic changes is known to vary; for example, the series of
reports from high incidence areas such as Japan, Italy, Portugal
and Korea show a range for MI varying from 15% to 39% (Han et
al, 1993; Chong et al, 1994; Rhyu et al, 1994; Strickler et al, 1994;
Lin et al, 1995; Chung et al, 1996; dos Santos et al, 1996; Ohue et
al, 1996; Renault et al, 1996). Although MI was noted in a high
percentage of gastric cancers with a positive family history
(Akiyama et al, 1996; Keller et al, 1996; Ottini et al, 1997),
germline or somatic mutations of the mismatch repetition and
repair (MMR) genes were rarely reported (Akiyama et al, 1996;
Keller et al, 1996). Thus, the mechanism leading to the mismatch
repair failure in gastric carcinomas remains largely unknown.
The association between Epstein—Barr virus (EBV) and gastric
cancer also varies among different populations, with the highest
positive association occurring in Caucasian populations (Shibata
and Weiss, 1992; Ott et al, 1994) and a low association seen in the
Japanese (Tokunaga et al, 1993). EBV is found in more than 80%
of a specific histological variant of gastric carcinoma, variably
termed lymphoepithelioma-like carcinoma (LELC), medullary or
gastric carcinoma with lymphoid stroma (Nakamura et al, 1994).
This variant is characterized by the presence of a poorly differenti-
ated morphology, a circumscribed border, an intense lymphoid
reaction and a better prognosis (Watanabe et al, 1976). The
possible relationship between EBV, MI and LELC is largely
unexplored except in one study from Japan, in which all eight 
EBV-associated gastric cancers were negative for MI (Chong
et al, 1994).
Previous data have shown that the mutator phenotype conferred
by MI has a significant role in carcinogenesis, in which it targets
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specific genes that play an important role in the growth-regulatory
pathway. The polyadenine tract in the type II transforming growth
factor b receptor (TbR-II) gene is one of the most commonly
mutated genes in MI-positive cancers. This leads to the inactiva-
tion of an important growth-suppressive pathway (Markowitz et
al, 1995; Myeroff et al, 1995; Parsons et al, 1995). Other genes
harbouring polynucleotide tracts are being increasingly demon-
strated to be affected, revealing the importance of MI in the
carcinogenic steps.
In Hong Kong, the population is more than 90% southern
Chinese and the annual incidence of gastric cancer is 13.2, an
intermediate incidence area (Hong Kong Cancer Registry, 1996).
This study examines the incidence of MI in gastric cancer in Hong
Kong Chinese when correlated with various clinicopathological
parameters. The relationship of MI with EBV, mutation of the
polynucleotide tract of TbR-II, BAX and insulin-like growth
factor II receptor (IGF-IIR) were particularly examined, in an
attempt to further elucidate the role of MI in carcinogenesis.
MATERIALS AND METHODS
Materials
Seventy-nine cases of gastric carcinoma from Hong Kong Chinese
were studied, with the series consisting of 18 cases of EBV-associ-
ated and 61 EBV-negative gastric carcinomas. The EBV-associated
cases were derived from the screening of 290 non-consecutive
gastric carcinomas from 1986 to 1997 using in situ hybridization to
detect EBV-encoded RNAs (EBER), as described previously (Yuen
et al, 1994). The EBV-negative cases were from gastrectomy spec-
imens performed in the period 1993—97 for whom frozen blocks
were still available. Paired tumour and normal tissue blocks were
selected. The normal tissue was dissected away as much as possible
in the tumour blocks, and cryostat or paraffin sections were cut and
examined to confirm the tumour cell percentage. Only those
tumour blocks containing more than 30% tumour cells were
selected. The normal blocks were similarly examined to ensure the
absence of tumour cell contamination. Sections were cut, deparaf-
finized as needed and suspended in proteinase K buffer. DNA was
purified using a standard proteinase K digestion, phenol—chloro-
form extraction method.
Methods
Eight loci were used to evaluate the MI status. These included five
dinucleotide repeats (Tp53, D18S58, D18S57, D2S123, D5S346)
and three mononucleotide repeats of polyadenine tracts (BAT26,
BAT40 and BAT-RII). Tp53, D18S58, D18S57, D2S123 and
D5S346 were purchased from Research Genetics (Huntsville, AL,
USA). BAT26 and BAT40 were synthesized according to the
sequence published previously (Liu et al, 1996). For D2S123 and
D18S58, additional sets of primers synthesized according to the
published sequence (Liu et al, 1996) were also used. The BAT-RII,
synthesized according to Myeroff et al (1995), amplify a 73-bp
region of the TbR-II gene. These span nucleotides 665—737, which
contain a polyadenine tract. In 87% of cases, seven to eight loci
were analysed. In the remaining 13%, at least five of these eight
loci were analysed, including both dinucleotide and polyadenine
repeats.
The primer sequences for BAX were the same as those
described by Rampino et al (1997), and amplified a segment
containing eight consecutive deoxyguanosines spanning codons
38—41. The primer for IGF-IIR amplified a segment spanning
nucleotides 4030—4140, which contained an eight-deoxyguanine
repeat (Souza et al, 1996). All cases with microsatellite instability
were analysed for frameshift mutation in the BAX and IGF-IIR
gene. An additional 48 MI-negative cases were also analysed for
BAX mutation.
The polymerase chain reaction (PCR) was performed in a 10-ml
reaction solution containing 50 ng of DNA, 10 mM Tris (pH 8.3),
50 mM potassium chloride, 2—3 mM Mg2+, 200 mM dNTP, 1 mCi
of [a-32P]dCTP, 0.2—1 mM of each primers and 0.1 U Taq
polymerase. Hot-start reaction was performed by preheating the
mixture in the thermocycler at 95°C for 5 min, then 80°C before
adding the Taq polymerase. An initial denaturation step of 95°C
for 5 min and 25—40 cycles including 95°C for 45 s (1 min), 1 min
(1.5 min) in 52—64°C annealing temperature according to the
specific primers, and 72°C for 1 min (2 min) in frozen DNA
(paraffin DNA) was performed, followed by a final extension of
5 min at 72°C.
The PCR products were diluted by loading buffer, heated at 95°C
for 5 min and loaded onto 7% vertical polyacrylamide gel. After
electrophoresis, the gels were fixed and dried and exposed to 
radiographic film for between 12 h and 7 days. The band patterns
between the tumour and non-tumour tissue were compared and
scored by two independent investigators. All cases with alteration of
band sizes in the tumour tissue compared with normal were repeated
once. The number of loci showing microsatellite instability were
recorded in each case. Cases with >40% unstable loci, including both
types of repeats, were classified as high-level MIs. Cases with
1—40% unstable loci were classified as low-level MIs.
RESULTS
Microsatellite instability was detected in 13 cases (16.5%);
including ten (12.7%) high-level MIs and three (3.8%) low-level
MIs (Table 1). The high-level MIs tended to have lots of unstable
loci involving both dinucleotide and mononucleotide repeats,
whereas the low-level MIs tended to affect the mononucleotide
repeats only. Although two of the high-level MIs were also EBV
associated, the incidence of high-level MI was similar for the
EBV-positive (11%) and EBV-negative cases (13%). Of the ten
high-level MIs, eight (80%) had frameshift mutation in the A10
tract of TbR-II and four (40%) had frameshift mutation in the G8
tract of BAX gene. All cases with BAX mutation also had 
mutation of the TbR-II gene. One of the three (33%) low-level
MIs had mutation of the A10 tract of TbR-II. No mutation of the
IGF-IIR gene was detected in any of the MI cases. Mutation of
TbR-II and BAX was not detected in any of the MI-negative cases.
Representative results of the microsatellite analysis are shown in
Figures 1 and 2.
The relationship between MI and EBV status and clinicopatho-
logical parameters is shown in Tables 2 and 3. All the high-level
MIs were of intestinal type, which differs significantly from the
low-level and negative MIs (Fisher exact test, P = 0.03). The 
high-level MIs also had a significantly more prominent lymphoid
infiltrate (Fisher exact test, P = 0.04). Three cases had the
morphological characteristic of LELC, two were EBV positive
and MI negative, whereas one was EBV negative but with high-
level MI. The EBV-associated cases were most commonly located
in the gastric body (chi-squared test, P < 0.00001), whereas the
high-level MIs were mostly located in the antrum but did not reach584 SY Leung et al
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statistical significance. There were 13 cases from the cardia and
all were negative for high-level MI and EBV. There was no signif-
icant association for high-level MIs or EBV status with sex,
tumour differentiation, tumour depth of invasion or lymph node
metastasis.
Both high-level and low-level MIs were found in patients aged
55 or above. None of the 15 patients aged below 55 showed MI.
Although comparison of high-level MIs compared with low/nega-
tive MIs did not quite reach statistical significance (Fisher exact
test, P = 0.1), the difference between negative and low-/high-level
MIs was significant (chi-squared test, P = 0.049).
DISCUSSION
This study detected the presence of high-level MI in 12.7% of
gastric carcinomas in Hong Kong Chinese. Though the overall
incidence of MI in our series is low (16.5%), the incidence of high-
level MI is either similar (Han et al, 1993; Chong et al, 1994;
Strickler et al, 1994; Ohue et al, 1996; Ottini et al, 1997) or only
slightly lower (Rhyu et al, 1994; Chung et al, 1996; dos Santos et
al, 1996) when compared with many large series from high-inci-
dence areas. Although the low-level MI cases may simply repre-
sent an inherent instability of repeat sequences in cancer tissue, the
high-level MI cases are highly suggestive of defects in the DNA
mismatch repair systems. In fact, a criteria of more than 40%
unstable loci were advocated by some groups to qualify a case as
MI (Bocker et al, 1997; Dietmaier et al, 1997). Our study has 
identified a specific clinicopathological profile in patients with
high-level MIs: they are all elderly patients, the tumours are of
intestinal type and show a significantly more intense lymphoid
infiltrate. Also, location in the antrum is more common.
Our results confirm the previous observations of dos Santos et al
(1996), who demonstrated more prominent lymphoid infiltrate in
gastric carcinoma when there was a high level of MI. This invites
comparison with those MI-positive colorectal carcinomas in which
Crohn￿s disease-like lymphoid reaction is also more commonly
seen (Kim et al, 1994). Our study included three LELC cases; two
were EBV associated with negative MI, and one was EBV 
Table 1 Clinicopathological features, mutation of the TbR-II, BAX and IGF-IIR genes in microsatellite instability (MI)-positive
gastric carcinomas
Patient 1 2 3 4 5 6 7 8 9 10 11 12 13
Sex F M F M F M M M F M F F M
Age 77 59 77 78 65 66 63 57 79 79 79 73 55
Tumour site C C A B B A A A A B A A A
Laurens’ type I I D I I I I I I Ib II I
Lymphoid infiltrate 1 0 0 2 2 0 2 2 1 3 3 0 2
EBV status 0 0 0 1 1 0 0 0 0 0 0 0 0
Tp53 0 0 0 0 1 1 1 1 1 1 1 1 1
D18S58 0 0 0 ND 1 1 1 1 1 0 1 1 1
D18S57 0 ND 0 ND ND 1 0 0 0 ND ND ND 1
D2S123 0 0 0 1 1 0 0 1 0 1 1 1 1
D5S346 0 0 0 0 0 1 1 0 1 1 ND 1 1
BAT26 0 0 0 0 0 0 1 1 1 1 1 1 1
BAT40 1 1 1 1 1 1 1 1 1 1 1 1 1
BAT-RII 0 0 1 1 0 0 1 1 1 1 1 1 1
No. of MI/locia 1/8 1/7 2/8 3/6 4/7 5/8 6/8 6/8 6/8 6/7 6/6 7/7 8/8
% Unstable loci 13 14 25 50 57 63 75 75 75 86 100 100 100
BAX (G8 tract) 0 0 0 1 0 0 0 1 1 0 0 1 0
IGF-IIR (G8 tract) 0 0 0 0 0 0 0 0 0 0 0 0 0
Tumour site: C, cardia; B, body; A, antrum; Laurens’ tumour type: I, intestinal; D, diffuse; Lymphoid infiltrate: 0, minimal; 1, mild;
2, moderate; 3, intense; EBV status; 0, negative; 1, positive; microsatellite instability; 0, negative; 1, positive; ND, not
determined; ainclusive of BAT-RII (A10 tract of TbRII); bthis is a case of lymphoepithelioma-like carcinoma.
N  T N  T N  T N  T N  T N  T N  T N  T
AB C D E F G H
Figure 1 Microsatellite alteration at various loci in gastric carcinoma.
(A) Tp53; (B) D2S123; (C) D18S58; (D) BAT40; (E) BAT26; (F) BAT-RII;
(G) D18S57; (H) D5S346. N, normal tissue; T, tumour tissue
N  T N  T
BAX IGF-IIR
Figure 2 Frameshift mutation is noted in the BAX gene but absent in the
IGF-IIR gene. N, normal tissue; T, tumour tissueMicrosatellite instability in gastric carcinomas 585
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negative but showed high-level MI. There is also a reported series
of 13 colonic medullary carcinomas which were all EBV negative
but MI positive (Ruschoff et al, 1997). Thus, it appears that MI
may contribute to a subset of carcinoma with the morphological
features of LELC/medullary carcinoma. The lymphoid reaction in
LELC with MI may be triggered by more frequent genetic errors
resulting in formation of mutated immunogenic proteins, or, in the
EBV-associated cases, by expression of certain viral antigens in
the carcinoma cells.
The association of high-level MI with intestinal type tumour
and antral location correlate well with the results of Chung et al
(1996) and Ottini et al (1997). Although EBV-associated cases
were also more commonly seen in intestinal type tumours with
intense lymphoid infiltrate, these were mostly located in the
gastric body. In this series, none of the carcinoma in the cardia
were associated with EBV or high-level MI. This poses an 
interesting question concerning regional susceptibility of the
stomach to different carcinogenic pathways.
The mutator phenotype conferred by MI plays an important role
in carcinogenesis. In previous series, insertion/deletions in the
polyadenine tract of TGF-bRII genes has been detected in more
than 70% of gastric carcinomas with MI (Myeroff et al, 1995;
Chung et al, 1996; Yamamoto et al, 1997). We also found muta-
tions of TbR-II in 80% of gastric carcinomas with high-level MI,
one of which was seen in an EBV-associated case. It is interesting
to note that in 70% of the tumours with high-level MIs, there is a
moderate to intense lymphoid infiltrate. Now, as TGF-b is a potent
growth inhibitor of epithelial cells as well as a potent immuno-
suppressive cytokine (Kehrl, 1991; Wojtowicz Praga, 1997), the
cancer cells with mutated TbR-II may be both released from the
growth-inhibitory effect of TGF-b and yet benefit from its
immunosuppressive effect.
The BAX gene is an antagonist of Bcl-2, and promotes apop-
tosis. Inactivation of this gene due to frameshift mutation in the GI
tract was first reported to occur in more than 50% of MI-positive
colorectal carcinomas (Rampino et al, 1997). Two subsequent
series reported a total of 20 BAX frameshift mutations in 31 MI-
positive gastric carcinomas (65%) (Chung et al, 1997; Yamamoto
et al, 1997). In the current series, we found BAX mutation in 40%
of the high-level MIs. None of the low-level MIs or MI-negative
cases showed this type of frameshift mutation. Moreover, all cases
with BAX mutation also showed mutation in TbR-II. This
supports the notion that, although MI causes mutation in a random
fashion, only specific genes involved in control of cell cycle or
apoptosis were selected for in the carcinogenic process.
Interestingly, none of the MI-positive cases in our series showed
IGF-IIR mutation. There have only been a few reports on mutation
of this gene in gastric cancers but in most series the incidence of
mutation is low, ranging from 8% to 33% (Souza et al, 1996;
Chung et al, 1997; Ouyang et al, 1997; Yamamoto et al, 1997).
Table 2 Microsatellite instability and clinicopathological features in 79 gastric carcinomas
MI-negative Low-level MI High-level MI Total P-valuea
(0% locus) (1–40% loci) (>40% loci)
Sex
M 49 (14) 1 6 (1) 56
F 17 (2) 2 4 (1) 23
Age groups (years)
<45 12 (4) 0 0 12 P = 0.1b
45–54 3 0 0 3 High vs low/negative MI,
55–64 20 (6) 1 3 24 <55 vs 55+
65+ 31 (6) 2 7 (2) 40
Differentiation
Moderate 26 (5) 2 5 33
Poor 40 (11) 1 5 (2) 46
Tumour type
Intestinal 45 (14c)2 1 0 d (2) 57 P = 0.03
Diffuse 13 1 0 14 High vs low/negative MI,
Mixed 8 (2) 0 0 8 Intestinal vs diffuse/mixed
Tumour site
Cardia 11 2 0 13
Body 21 (12) 0 3 (2) 24
Antrum 34 (4) 1 7 42
Lymphoid infiltrate
Minimal/mild 42 (5) 3 3 48 P = 0.04
Moderate/severe 24 (11) 0 7 (2) 31 High vs low/negative MI
Tumour level
Submucosa 2 (1) 0 0 2
Muscle 7 (1) 1 4 12
Serosa 57 (14) 2 6 (2) 65
Lymph node
Negative 13 (2) 0 2 15
Positive 53 (14) 3 8 (2) 64
aFisher exact test, one tail; bMI negative vs low-/high-level MI, <55 vs 55+, P = 0.049; numbers in parentheses equal to number
of EBV-positive cases; cinclusive of two cases of LELC; dinclusive of one case of LELC.586 SY Leung et al
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Also, tumours tend to be positive for either TbR-II or IGF-IIR
mutation, but not both (Souza et al, 1996). This can be explained
by the fact that IGF-IIR is required for the activation of the TGF-
b1 complex from its latent form so that they may constitute serial
points in the same carcinogenic pathway (Souza et al, 1996).
Because most of the high-level MIs are positive for TbR-II muta-
tion in our series, the absence of IGF-IIR mutation is consistent
with the hypothesis. In summary, inactivation of TbR-II appears to
be the most common and important pathway targeted by MI in
gastric carcinomas, followed by BAX gene, whereas mutation of
IGF-IIR is relatively uncommon.
We found high-level MI in both EBV-negative as well as EBV-
positive gastric carcinomas. This is in contrast to a previous study by
Chong et al (1994), who found no MI in eight EBV-associated
gastric carcinomas. Whether MI is present in other EBV-associated
carcinomas is not known. The possibility that MI is caused by the
human immunodeficiency virus (HIV) has been raised by a group
of investigators who detected a high incidence of MI in 
B-cell non-Hodgkin￿s lymphoma and in Kaposi sarcoma 
developing in patients with the acquired immunodeficiency
syndrome (AIDS) (Bedi et al, 1995). Because a high proportion of
B-cell non-Hodgkin￿s lymphoma in AIDS patients are associated
with EBV (Shibata et al, 1993; Hamilton Dutoit and Pallesen, 1994;
Anagnostopoulos and Hummel, 1996), and human herpesvirus 8 is
present in Kaposi sarcoma (Schalling et al, 1995), it would be most
useful to determine whether the MI observed in these tumours was
related to the HIV or the other two herpes viruses.
Although there is a high incidence of MI in young colorectal
cancer patients both in Hong Kong (Chan et al, 1997) and else-
where (Liu et al, 1995), this does not seem to be so in gastric
cancer. None of the 12 gastric cancer patients aged below 45 in our
series showed MI, and all the MI cases were aged 55 or above.
Thus, although gastric cancer is within the spectrum of HNPCC-
related tumours, it cannot account for the young gastric cancer in
our population.
In summary, MI may constitute an important carcinogenic
pathway in a specific clinicopathological subgroup of gastric
carcinoma through inactivation of specific growth regulatory
genes. The mechanism leading to MI in these sporadic gastric
carcinomas is an area for further studies.
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Table 3 EBV and the clinicopathological features in 79 gastric carcinomas
EBV-negative EBV positive Total P-valuea
Sex
M 41 (5) 15 (1) 56
F 20 (3) 3 (1) 23
Age groups (years)
<45 8 4 12
45–54 3 0 3
55–64 18 (3) 6 24
65+ 32 (5) 8 (2) 40
Differentiation
Moderate 28 (5) 5 33
Poor 33 (3) 13 (2) 46
Tumour type
Intestinal 41 (8b)1 6 c (2) 57 P = 0.07
Diffuse 14 0 14 Intestinal vs diffuse/mixed
Mixed 6 2 8
Tumour site
Cardia 13 0 13 P < 0.00001
Body 10 (1) 14 (2) 24
Antrum 38 (7) 4 42
Lymphoid infiltrate
Minimal/mild 43 (3) 5 48 P = 0.001
Moderate/severe 18 (5) 13 (2) 31
Tumour level
Submucosa 1 1 2
Muscle 11 (4) 1 12
Serosa 49 (4) 16 (2) 65
Lymph node
Negative 13 (2) 2 15
Positive 48 (6) 16 (2) 64
aChi-squared test; numbers in parentheses equal to number of high-level MI cases; binclusive of one case of LELC; cinclusive of
two cases of LELC.Microsatellite instability in gastric carcinomas 587
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